Filtrer vos résultats
- 3
- 1
- 3
- 1
- 3
- 2
- 1
- 2
- 1
- 4
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
4 résultats
|
|
|
triés par
|
|
|
What do we mean by identiability in mixed effects models?Journal of Pharmacokinetics and Pharmacodynamics, 2016
Article dans une revue
hal-01365535v1
|
||
|
|
What do we mean by identifiability in mixed effects models?2016
Pré-publication, Document de travail
hal-01251986v1
|
||
|
|
Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patientsMathematical Medicine and Biology, 2017, ⟨10.1093/imammb/dqw019⟩
Article dans une revue
hal-01568372v1
|
||
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexateJournal of Pharmacokinetics and Pharmacodynamics, 2014, 41 (2), pp.173-185
Article dans une revue
hal-02045750v1
|